TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
Alfimed AS
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
20,924
|
19,172
|
19,959 |
Financial expenses |
864
|
5
|
1 |
Earnings before taxes |
3,432
|
4,836
|
7,436 |
Total assets |
9,648
|
10,287
|
11,363 |
Current assets |
9,443
|
10,051
|
11,220 |
Current liabilities |
6,548
|
6,423
|
8,454 |
Equity capital |
3,101
|
3,864
|
2,908 |
- share capital |
99
|
106
|
103 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
32.1%
|
37.6%
|
25.6% |
Turnover per employee | |||
Profit as a percentage of turnover |
16.4%
|
25.2%
|
37.3% |
Return on assets (ROA) |
44.5%
|
47.1%
|
65.4% |
Current ratio |
144.2%
|
156.5%
|
132.7% |
Return on equity (ROE) |
110.7%
|
125.2%
|
255.7% |
Change turnover |
3,023
|
-1,405
|
5,876 |
Change turnover % |
17%
|
-7%
|
42% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.